Assessment of the feed additive consisting of Lactococcus lactis NCIMB 30117 for all animal species for the renewal of its authorisation (Chr. Hansen A/S). (21st April 2022)

• Record Type: Journal Article
• Authors: Bampidis, Vasileios; Azimonti, Giovanna; Bastos, Maria de Lourdes; Christensen, Henrik; Dusemund, Birgit; Fašmon Durjava, Mojca; Kouba, Maryline; López‐Alonso, Marta; López Puente, Secundino; Marcon, Francesca; Mayo, Baltasar; Pechová, Alena; Petkova, Mariana; Ramos, Fernando; Sanz, Yolanda; Villa, Roberto Edoardo; Woutersen, Ruud; Saarela, Maria; Brozzi, Rosella; Galobart, Jaume; Gregoretti, Lucilla; Revez, Joana
• Is Part Of: EFSA journal. Volume 20:Number 4(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-04-21
• Subjects: Technological additives -- silage additive -- Lactococcus lactis NCIMB 30117 -- safety -- efficacy -- QPS -- renewal; Food -- Europe -- Safety measures -- Periodicals; Food Safety; Food -- Safety measures; Europe; Periodicals; Periodicals; Fulltext; Government Publications, International; Internet Resources; Periodicals; Periodicals; 363.19209405
• DOI: 10.2903/j.efsa.2022.7243
• Languages: English
• ISSNs: 1831-4732

Abstract

Abstract: Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Lactococcus lactis NCIMB 30117 as a technological additive for use in forage for all animal species. The additive aims to improve the production of silage and is authorised for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for all animal species, consumer and the environment under the authorised conditions of use. Regarding user safety, the additive should be considered as a respiratory sensitiser. No conclusions can be drawn on the skin sensitisation, and eye and skin irritancy potential of the additive. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.